Skip to content
Search AI Powered

Latest Stories

'210 pharmacies to test-run NHSE’s independent prescribing pathfinder programme'

NHS England plans to include 210 community pharmacy sites across 42 integrated care boards in the initial phase of its independent prescribing pathfinder program. This initiative aims to evaluate diverse prescribing models, while refining the framework for commissioning independent prescribing within community pharmacy clinical services.

According to the NHSE, each ICB will define the scope of its facilities to test the application of community pharmacy independent prescribing for delivering commissioned services. NHSE launched an expression of interest process for integrated care systems to join the Pathfinder Programme in January this year.


On its website's information page, NHSE said that the independent prescribing pathfinder program offers a unique opportunity for community pharmacy to redesign existing pathways and expand its role in providing clinical services within primary care.

NHSE said that ICBs will be urged to fully utilise the skills and capabilities of community pharmacists to enhance clinical services that are already commissioned as advanced pharmaceutical services or to integrate them into locally commissioned services.

ICBs will work with community pharmacy teams to identify pharmacies and local pharmacists for service delivery through the establishment of pathfinder sites. They will also coordinate with other NHS bodies, local authorities, and community organisations engaged in providing integrated care services, the NHSE added.

"The launch of pathfinder sites is a positive step, especially as every ICB can now participate," said Alastair Buxton, Director of NHS Services at Community Pharmacy England. "The program enables the NHS and community pharmacy to collaboratively address practical and professional concerns essential for the integration of independent prescribing into everyday practice and the NHS contractual framework."

Buxton said that independent prescribing will be central to numerous future services offered by community pharmacists, aligning with the sector's Vision formulated by Nuffield Trust and The King’s Fund for Community Pharmacy England.

"We are really excited about how independent prescribing will bolster the advancement of community pharmacy services, optimising the clinical skills of pharmacists for the benefit of patients and the NHS," he added.

In June, the Company Chemists’ Association emphasised increased ambition, speed, and a bold approach from the government and NHS towards harnessing pharmacist independent prescribing. All pharmacists registering post-2026 will acquire independent prescribing capabilities. An estimated 23,000 pharmacists in England lack IP qualifications. As per current plans, training the entire workforce is projected for completion by 2040, according to the CCA.

The Association highlighted that investing in community pharmacy expands NHS capacity, boosts primary care resilience, and enhances patient outcomes.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less